The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

A.G. Shchuko

GOU VPO "Irkutskiĭ gosudarstvennyĭ meditsinskiĭ universitet"

N.V. Zaĭtseva

Irkutskiĭ filial FGBU "MNTK "Mikrokhirurgiia glaza" im. akad. S.N. Fedorova

T.N. Iur'eva

Irkutskiĭ filial FGBU "MNTK "Mikrokhirurgiia glaza" im. akad. S.N. Fedorova

E.R. Chernykh

Research Institute of Fundamental and Clinical Immunology, 14 Yadrintsevskaya St., Novosibirsk, Russian Federation, 630099

I.M. Mickhalevich

Irkutsk State Medical Academy of Postgraduate Education — Branch Campus of the Federal State Budgetary Educational Institution of Further Professional Education «Russian Medical Academy of Continuous Professional Education», Irkutsk, Russia

A.V. Grigor’eva

Irkutsk Branch of the Academician S.N. Fyodorov IRTC “Eye Microsurgery”, Ministry of Health of the Russian Federation, 337 Lermontova St., Irkutsk, Russian Federation, 664033

Role of immunological factors in the development of myopic choroidal neovascularization

Authors:

A.G. Shchuko, N.V. Zaĭtseva, T.N. Iur'eva, E.R. Chernykh, I.M. Mickhalevich, A.V. Grigor’eva

More about the authors

Journal: Russian Annals of Ophthalmology. 2016;132(5): 5‑14

Views: 1076

Downloaded: 21


To cite this article:

Shchuko AG, Zaĭtseva NV, Iur'eva TN, Chernykh ER, Mickhalevich IM, Grigor’eva AV. Role of immunological factors in the development of myopic choroidal neovascularization. Russian Annals of Ophthalmology. 2016;132(5):5‑14. (In Russ.)
https://doi.org/10.17116/oftalma201613255-14

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.